Basiliximab (Simulect) for the treatment of steroid-resistant rejection in pediatric liver transpland recipients: a preliminary experience.

M M Aw; R M Taylor; A Verma; A Parke; A J Baker; D Hadzic; P Muiesan; M Rela; N D Heaton; G Mieli-Vergani

doi:10.1097/01.TP.0000054682.53834.EA

Basiliximab (Simulect) for the treatment of steroid-resistant rejection in pediatric liver transpland recipients: a preliminary experience.

Identifier:nobleid.org/w1/20260515/7419B686

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/7419B686.svg?ark=w1%2F20260515%2F7419B686)](https://nobleid.org/work/w1/20260515/7419B686)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Basiliximab (Simulect) for the treatment of steroid-resistant rejection in pediatric liver transpland recipients: a preliminary experience.

Identifier:nobleid.org/w1/20260515/7419B686

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/7419B686.svg?ark=w1%2F20260515%2F7419B686)](https://nobleid.org/work/w1/20260515/7419B686)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work